Polycystic ovary syndrome (PCOS) is a common endocrine disorder in women of reproductive age, affecting around 5-10% of this population. It is characterized by hormonal imbalances, irregular menstrual periods, and the development of small cysts on the ovaries. One of the most challenging symptoms of PCOS is weight gain and difficulty in losing weight. Women with PCOS often struggle with obesity and related complications such as insulin resistance, type 2 diabetes, and cardiovascular disease. Traditional weight loss methods like diet and exercise may not always be effective in managing weight in PCOS patients. However, recent studies have shown promising results with the use of semaglutide, a medication typically used for type 2 diabetes, in helping PCOS patients achieve weight loss.
Semaglutide and PCOS Weight Loss
Semaglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist that works by mimicking the effects of the naturally occurring hormone GLP-1. It helps regulate blood sugar levels, suppresses appetite, and promotes satiety, leading to reduced calorie intake and weight loss. In recent years, semaglutide has gained attention for its potential in managing weight in individuals with obesity and related conditions, including PCOS.
A randomized controlled trial published in the Journal of Clinical Endocrinology & Metabolism in 2020 investigated the effects of semaglutide on weight loss in women with PCOS. The study found that participants who received semaglutide injections lost significantly more weight compared to those who received a placebo. The results highlighted the potential of semaglutide as a promising treatment option for weight management in PCOS patients.
Mechanism of Action
Semaglutide works by increasing insulin secretion, decreasing glucagon secretion, slowing gastric emptying, and reducing food intake through its effect on the central nervous system. The medication binds to GLP-1 receptors in the pancreas, brain, and other tissues, regulating glucose metabolism and energy balance. By modulating these pathways, semaglutide helps individuals with PCOS achieve weight loss and improve metabolic parameters.
Additionally, semaglutide has been shown to improve insulin sensitivity and reduce inflammation, both of which are important factors in the management of PCOS. Insulin resistance is a common feature of PCOS, leading to elevated insulin levels, increased androgen production, and ovulatory dysfunction. By targeting insulin resistance and inflammatory pathways, semaglutide can address underlying metabolic abnormalities and promote weight loss in PCOS patients.
Clinical Considerations
Before starting treatment with semaglutide, PCOS patients should undergo a thorough medical evaluation to assess their overall health status and individual treatment goals. Semaglutide is typically administered as a once-weekly subcutaneous injection, gradually increasing the dosage to minimize side effects and maximize weight loss benefits. Patients may experience gastrointestinal symptoms such as nausea, vomiting, and diarrhea, which usually improve over time as the body adjusts to the medication.
It is essential for PCOS patients to work closely with healthcare providers, including endocrinologists, gynecologists, and nutritionists, to develop a comprehensive treatment plan that includes lifestyle modifications, dietary changes, and regular monitoring of metabolic parameters. Semaglutide should be used as part of a holistic approach to weight management in PCOS, focusing on long-term sustainability and overall health improvement.
Future Directions
Research on semaglutide and its role in weight management in PCOS patients is ongoing, with several clinical trials currently underway to further explore its efficacy and safety. As our understanding of PCOS and its metabolic consequences continues to evolve, semaglutide and other GLP-1 receptor agonists may emerge as key therapeutic options for addressing weight gain and related complications in women with PCOS. By integrating pharmacological interventions with lifestyle modifications and personalized care, healthcare providers can better support PCOS patients in achieving sustainable weight loss and improving their overall quality of life.
http://www.petsbest.com
In Part II of this series, Dr. Matheys discusses ways to treat hyperthyroid in cats using diet and medication, as well as the potential side effects and pitfalls of each.
Watch Part I: http://youtu.be/sTVqOInCW74
Watch Part III: http://youtu.be/HPW6tBxqrUY
Insurance Verification And Prior Auth Process Zappy GLP 1
Read full Article: https://staffingly.com/end-to-end-process-for-verifying-eligibility-and-initiating-pa-for-wegovy-zepound/
This one’s for providers who want to understand how Zappy Health verifies insurance and secures prior authorization for GLP-1 medications like Wegovy and Zepbound.
From checking plan benefits in real-time to preparing insurer-specific documentation, our team handles the details that often cause delays. Watch how our ePA workflow reduces friction and supports better patient outcomes with less administrative burden on your part.
𝗗𝗶𝘀𝗰𝗹𝗮𝗶𝗺𝗲𝗿
For informational purposes only; not applicable to specific situations.
For tailored support and professional services,
please contact Staffingly, Inc. at (800) 489-5877
Email : [email protected].
#priorauthorization #staffingly #outsourcing #healthcare #healthcareoutsourcing
Oats for weight loss? A study suggests oats, rich in beta-glucan, mimic Ozempic's effects! Eat oats & lose weight. #weightlossjourney #healthylifestyle #oatmeal #ozempic #science #nutrition
Calculate your Calorie Deficit for FREE and start burning fat today.
👉🏻 https://spartan-fitness.com/cc
Drop 10–20LBS of Fat in the next 10 weeks (and keep it off forever!)
👉🏻 https://spartan-fitness.com/join
===
Are you struggling to lose belly fat and not sure why? In this video, I reveal the 6 mistakes that stop 93% of men from losing their belly fat.
These are the same mistakes I made before dropping 50 pounds in 4 months. From unrealistic expectations to diet myths and lack of systems, I'll break down exactly what’s holding you back and how to fix it.
Learn about the importance of sustainable habits, the role of protein and fibre in fat loss, how hydration can boost your energy, and why not all calories are created equal.
Plus, I’ll show you a simple way to calculate your calorie target and make weight loss easier without giving up your favourite foods or wasting hours in the gym.
Metformin is a first-choice medication to help manage blood sugar levels in Type 2 diabetes, but it's used in other situations too, like prediabetes. It lessens sugar absorption and production, and it makes your body more sensitive to insulin. This helps lower the amount of sugar in your blood.
It's also help to reduce weight.
Side effects of metformin include:-
Diarrhea.
Physical weakness (asthenia)
Gas (flatulence)
Upper Respiratory Tract Infection.
Low Blood Sugar (hypoglycemia)
Abdominal Pain (GI complaints),
Lactic Acidosis (rare).
#DrAsifIzhar
#Glucophage
#Metformin
#TabletMetformin
#tabletGlucophage500mg
Resources for the Community
___________________________________________________________________
https://linktr.ee/theplussidezpodcast
Ro - Telehealth for GLP1 weight management
https://ro.co/weight-loss/?utm_source=plussidez&utm_medium=partnership&utm_campaign=comms_yt&utm_content=45497&utm_term=55
Find Your US Representatives
https://www.usa.gov/elected-officials
United States Patent & Trademark Office Website and Email
https://www.uspto.gov/
[email protected]
i-MAK Website
https://www.i-mak.org/
i-MAK Briefs & Reports
https://www.i-mak.org/resource-type/briefs/
______________________________________________________________________
Tahir Amin, founder of I-MAK, joins us to break down why GLP-1 meds like Ozempic and Mounjaro stay so pricey. We dig into evergreening, patent thickets, and how pharma companies use legal loopholes to delay generics and extend monopolies.
We also explore why some companies spend more on stock buybacks than drug innovation—and what that means for access. If you’ve felt exploited by the system, you’re not alone. But there’s hope. Learn about the policy changes ahead and how you can take action to fight for affordable meds.
Tahir Amin bio:
Tahir Amin is a founder and CEO of the Initiative for Medicines, Access & Knowledge (I-MAK), a nonprofit organisation working to address the systemic inequities in how medicines are developed and distributed. He has over 30 years of experience in intellectual property (IP) law, during which he has practised with two of the leading IP law firms in the United Kingdom and served as IP Counsel for multinational corporations. His work focuses on changing the structural power dynamics that allow health and economic inequities to persist by challenging and re-shaping IP laws and the related global political economy to better serve the public interest. He is a former Harvard Medical School Fellow in the Department of Global Health & Social Medicine and has served as legal advisor/consultant to many international groups, including the European Patent Office and World Health Organization, as well as testifying before the U.S. Congress on intellectual property and unsustainable drug prices.
Special Guest Co-Host, Amanda Bonello from GLP-1 Collective
https://glp1collective.org/ ______________________________________________________________________
Join this channel to get access to perks:
/ @theplussidez
______________________________________________________________________
#Mounjaro #MounjaroJourney #Ozempic #Semaglutide #tirzepatide #GLP1 #Obesity #zepbound #wegovy
We discuss how losing body fat can dramatically change your face. See visual examples of bulk vs. cut, highlighting water retention and body fat percentages. Get ready for facial transformation! #FatLoss #FacialTransformation #WeightLoss #BodyFat #Fitness #Health #Cutting #Bulking #Nutrition #Diet
